Orca Bio
Orca Bio is a late-stage biotechnology company based in Menlo Park, California, with a manufacturing facility in Sacramento. Founded in 2016, the company specializes in high-precision, allogeneic cell therapies aimed at treating cancer, particularly blood cancers like acute myeloid leukemia and acute lymphocytic leukemia, as well as autoimmune diseases and genetic blood disorders. The company's mission is to redefine allogeneic stem cell transplants by delivering purified cell therapies that enhance survival rates and reduce risks associated with transplants. Orca Bio's lead investigational therapy, Orca-T, is currently in a pivotal Phase 3 trial and has received several designations from the FDA, including Regenerative Medicine Advanced Therapy. The company also focuses on developing additional therapies for various blood and immune disorders, supported by a state-of-the-art manufacturing facility capable of producing thousands of cell therapy products annually.
Work at Orca Bio in HR or recruiting? Claim this page
Headcount trend
Orca Bio went from 148 employees in Oct 2024 to 375 in Sep 2026. Apr to Sep 2026: 104 people joined, 16 left.
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Jun 2020 | Series D | $192M | 7 | |
| May 2018 | Series C | – | 1 | |
| Jan 2017 | Seed | – | – | – |
| May 2016 | Seed | – | – | – |
Org structure
Headcount by department
Peer reviews
Worked with someone at Orca Bio?
Anonymous peer reviews on OffTheRecord
Similar companies
Hiring now
Orca Bio FAQ
How many employees does Orca Bio have?
Orca Bio has about 375 employees, up 10% over the 3 months to Sep 2026.
What is Orca Bio's revenue per employee?
Orca Bio makes about $128K in revenue per employee, based on $48M annual revenue and 375 employees.
How much funding has Orca Bio raised?
Orca Bio has raised $192M in total funding; its latest round was Series D in Jun 2020.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.